1

13th UEDA CONFERENCEOF DIABETES

Hilton (Fairmont) Heliopolis, Cairo, Egypt

In collaboration with

Conference ChairmanAdel A. El-Sayed

UEDA PresidentDASG President

Conference SecretaryMesbah Sayed Kamel

UEDA Secretary GeneralDASG Executive Board Member

1 2

welcome letter UeDA BoAreD

On behalf of Prof. Adel A. El-Sayed and both DASG & UEDA Board I’d like to welcome each of you to the 13th Upper Egypt Diabetes Association Conference (UEDA), IDF member and the 6th Diabetes in Asia Study Group (DASG) bi-annual meeting. It’s an exciting time for diabetes care as the epidemic continues to grow nationally and internationally which necessitates motivated and responsive collaborative efforts from all whom are concerned. Diabetes is confronting a time of many changes and both DASG and UEDA are meeting these changes bringing inspired people together in Cairo, to ensure that our mission and vision remains at the cutting edge.I’d like to give you an idea of what you can expect and what we hope to achieve over this meeting. Utmost concern as usual is giving to young generations of health care providers who constitute the base of diabetes health care nationwide so a special pre-congress educational course will be arranged giving them basal knowledge and roadmap for better diabetes care using IDF modules.Six workshops discussing Life Style, Diabetic Foot, Obesity, Thyroid, Insulin and Polycystic Ovarian disease represent an important feature of our conference and will be led by experts in the field with young UEDA juniors to give them more experience and UEDA capacity building.A remarkable feature will be DASG-UEDA joint meeting in special session exploring and formulating a new collaborative design to improve diabetes care in all our members.Special consideration is given for NCDs where a joint meeting with WHO will be arranged to tailor a roadmap for collaboration and create new opportunities in low socio-economic situations.Top experts and eminent International, Regional and National speakers will share the event bringing their expertise to our conference as they have the vision, the knowledge, the wherewithal and the experience to help us pave our way into the future.You are cordially invited to attend this well- organized scientific meeting and to enjoy the magnificent history of Cairo and its beautiful March weather. Cairo offers wide variety of options to explore: great pyramids, wonderful monuments old and recent architecture, rich history, vibrant cultural life and great sightseeing opportunities.

Conference ChairmanAdel A. El-Sayed

DASG and UEDA President

Conference SecretaryMesbah Sayed KamelUEDA Secretary General

UEDA President

Adel A. El-SayedDASG PresidentDiabetes in Asia Study Group

Secretary GeneralMesbah Sayed KamelDASG Executive Board MemberDiabetes in Asia Study Group

TreasurerMohamed MashahitHead of Internal Medicine DepartmentHead of Diabetes and Endocrinology UnitFayoum Faculty of Medicine

Vice PresidentLobna Farag El-ToonyHead of Internal Medicine DepartmentsFormer of Diabetes and Endocrinology Unit Faculty of Medicine Assiut

Board MemberKhaled El-Sayed El-HadidyHead of Internal Medicine DepartmentHead of Diabetes and Endocrinology Unit Beni-Suef Faculty of Medicine

3 4

UeDA SUmmAry Profile iNterNAtioNAl GUeSt

Main Focus• Diabetes Education • Diabetes Prevention• Children with diabetes • Gestational Diabetes• Diabetes Updates • Participation in IDF activities

ActivitiesDiabetes Education: UEDA professional board organized 10 educational sessions for patients all over the Upper Egypt governorates: Fayoum, Beni Sweif, Minia, Assuit, Sohag, Luxor and Aswan.

World Diabetes Day: UEDA organizes• Awareness Campaigns and Educational sessions for patients and blood sugar measurement• Workshop for Training members on Diabetes awareness• Local Campaign in the streets, schools, universities, clubs

Scientific Research:• Clinical Trials to evaluate prevention program: This is a collaborative program with the German side (Dresden university) using the Image Module. It started in Minia & Sohag governorates, but now is to be implemented in other Egypt governorates under the auspices of UEDA.• Diabetes Dyslipedemia screening project.• National Diabetes registry.• GDM project care in Upper Egypt ( World diabetic federation ) • UEDA Eudecationsl Program (Minya and Qena)

Dr. Abdulla Al-Hamaq, Qatar mPH,PhD,frSPHDr. Al-Hamaq received his master Degree in Public Health , from school of medicine and Health Sciences, George washington University .USA , and his PH.D in the field of Public Health , from University of westminster ,london UK.

Dr. Abdel Aziz Hemidy, KSA1- Businessman.2- Director of Al-hamidi trading establishment from 1 february 1970 until 31/12/1980.3 - Director of the company Sickly Saudi (fire extinguishing plants) in Jeddah January 1/ 1981 until 30/4/1999.

Prof. Abdul Basit, Pakistan Director, Baqai Institute of Diabetology & Endocrinology (BIDE) Prof. of Medicine, Baqai Medical University (BMU)Qualifications: M.B.B.S, M.R.C.P. (UK), F.R.C.P. (UK).

Prof. Akhtar Hussain, Norway University of Oslo,Faculty of Medicine, Institute of Health and Society Department of International Health, NorwayAkhtar Hussain, Prof of Global Health Health (Chronic Diseases – Diabetes), Federal University of Ceara, Brazil since January 2017.

Dr Asher fawwad, Pakistan has completed his PhD from Baqai Medical University, Karachi – Pakistan. He is an Associate Professor of Biochemistry, Head of Research Department and Consultant Diabetologist at Baqai Institute of Diabetology and Endocrinology, Baqai Medical University.

5 6

iNterNAtioNAl GUeSt iNterNAtioNAl GUeSt

Prof. AK Azad Khan, BangladishMBBS (Dhaka), D. Phil. (Oxford), FCPS ( PK & BD.), FRCP (London) Honoris Causa Medicinae Doctorem (Basel, Switzerland)Honorary Fellow, University College London

Dr. Banshi Saboo, India chief Diabetologist & chairman of Diabetes care & Hormone clinic at Ahmedabad Honoured with Fellowship of American College of Endocrinology (USA), American College of Physician (USA), International College of Nutrition (FICN), Royal College of Physicians (Glasgow), MNAMS (Diabetology)

Dr. Bishwajit Bhowmik, BangladeshMBBS, DDM (UK), PhD Fellow (UIO, Norway)Coordinator, Centre for Global Health Research, Diabetic Association of Bangladesh. Published 25 scientific papers in international peer reviewed journals, 3 book chapters and editorial members of 14 books on diabetes and related NCDs.

Dr. Diaa ewais, KSA• MD. Consultant Internal Medicine - Saudi German Hospital• Chairman of Saudi German Hospital - Diabetes Conference

Dr. Gojka roglic, SwitzerlandDr Gojka Roglic has received training as physician and epidemiologist at the University of Zagreb, Croatia, and the London School of Hygiene and Tropical Medicine, London, UK. Dr Roglic is responsible for WHO activities on diabetes diagnosis, classification, management and individual level prevention

Dr. Hardik chandarana, Indiais HOD: Clinical Research & a Clinical podiatrist at Dia Care – AhmedabadActively involved in organizing many national conferences He is a Treasurer of AIAARO (Indian Obesity Society) & Indian Academy of Diabetes

Dr. ibtihal fadhil, UAE (MBChB , MSc, PhD, DipLSHTM) : NCD consultant, public health specialists, President of the Eastern Mediterranean NCD Alliance , Board Member of the Global NCD Alliance. As WHO Regional adviser for NCDs (2008-2016) she builds the regional NCD network for advocacy

Prof. Jamal Belkhadir, MoroccoFormer Professor, Department of Internal Medicine at the University of Rabat.Former Head of the Ibn Sina Hospital in Rabat.Specialist in Endocrinology and Metabolic Diseases, fields extend to diabetes, obesity, metabolic syndrome and the Ramadan fast.

Dr. Kebira Benabed, MoroccoFormer professor of internal Medicine at the University of RabatSpecialist in Endocrinology, Diabetology and NutritionFormer Secretary General of the Moroccan Society of Endocrinology, Diabetology and Nutrition (SMEDIAN)Member of the working group on Moroccan Guidelines for type 2 Diabetes

Prof. muhammad yakoob Ahmedani, PakistanDeputy Director, Baqai Institute of Diabetology & Endocrinology (BIDE) Prof. of Medicine, Baqai Medical University (BMU)Qualifications: M.B.B.S, F.C.P.S. (Pak).

7 8

iNterNAtioNAl GUeSt iNterNAtioNAl GUeSt

Dr. muhammad Abdus Samad, Bangladishone of the renowned Endocrinologists of Bangladesh is currently Working as Chief Executive Officer of National Healthcare Network one of the largest En-terprises of Diabetic Association of Bangladesh. He is graduated (MBBS) from Dhaka Medical College in 1984 & subsequently took his post graduation in Endocrinology & Metabolism in 1994 from University of Dhaka, Bangladesh

Dr. Nabil el Naggar, KSA Diabetologist & Head of Diabetes Center, Hai Aljamea Hospital.Chairman of Jeddah Diabetes Club.Chairmen of Jeddah Hypertension and Atherosclerosis Club.Head of CME Committee of Hai AlJamea Hospital, Jeddah, SA.

Prof. A. Samad Shera, PakistanSecretary General, Diabetic Association of Pakistan,Honorary President, International Diabetes Federation (IDF),Director, WHO Collaborating Centre for “Treatment, Education and Research in Diabetes and Diabetic Pregnancies”, Karachi – Pakistan,

Prof. Dr. Sehnaz Karadeniz, TurkeyAn ophthalmologist, Dr. Karadeniz has been actively involved in the field of diabetes for the past 20 years in a series of medical, scientific and social projects both at national and international levels.Currently she is a Teaching Faculty at the Ophthalmology Dept. of Medical Faculty of Istanbul Science University

Prof. Shabeen Naz masood, PakistanAn ophthalmologist, Dr. Karadeniz has been actively involved in the field of MBBS, MCPS, FICS, FCPS, PhD, DCPSProfessor Dr. Shabeen Naz Masood is doctorate in Obstetrics and Gynaecol-ogy, presently working as Professor & Head Department of Obstetrics and Gynaecology Isra University, Karachi Campus

Dr. Slim Slama, Lebanon

Dr. V. mohan, India is Chairman and Chief of Diabetology at Dr. Mohan’s Diabetes Specialities Centre in South India and also President and Director of the Madras Diabetes Research Foundation. Dr. Mohan has published over 1100 papers in peer reviewed journals.

Prof. m. Zaman Shaikh, PakistanPROFESSOR OF MEDICINE,SIR SYED COLLEGE OF MEDICAL SCIENCES, KARACHI.MBBS, FCPS, MRCP (UK), FRCPM.S.c (Diabetes & Endocrinology) (Glasgow University)

Dr. Sirelkhatim ismaeil Sirri, sudanMBBS faculty of medicine Juba universityMD of internal medicine SMSBAss professor of internal medicine Head department of inernal medicine faculty of medicine Omdurman Alahlia University

Prof. Sufian khalid mohammed Noor, SudanProfessor of medicine faculty of medicine nile valley university.Dean of the faculty of medicine.Published 30 scientific papers in different international journals Published more than 10 papers about diabetesPresident of the research committee in river nile state.

9 10

NAtioNAl fAcUlty GeNerAl iNformAtioN

Abbas orabi, Zagazig

Ahmed Abdel-kawy, Cairo

Alaa Abdel Salam, Monofiya

Ali Abdel-rahim, Alex

Aliaa Al Aghoury, Alex

Aml Khalifa, Sohag

Amr el-meligy, Cairo

Ashraf talaat, Banha

Asmaa kassem, Minya

Assem Zayada, Cairo

Ayman Almonofy, Fayoum

Basma Abdel-moez, Minya

emad Hamed, Qena

emad meshriki, Tanta

eman el-Shorbagy, Zagazig

eman ezzat, Fayoum

eman thabet, Sohag

engy Abdel-wahhab, Tanta

fahmy Amara, Alex

fareed fawzy, Zagazig

fawzy el mosalamy, Zagazig

Gehan AbdelKader, Zagazig

Ghada el-Sagheer, Minya

Hala el toukhy, Fayoum

Hala elebidi, Aswan

Hala el-Sherif, Assiut

Hanaa Kandeel, Al-Azhar

Hanan Gawish, Mansoura

Hanan mahmoud, Assiut

Hany Hamed, Beni suef

Hassan mohy el-Dien, Minya

Hemat elewaa, Cairo

Hesham el-Hefnawy, NIDE

Huda Hussien, Fayoum

ibtisam Zakaria, Cairo

ihab Salem, Zagazig

inass Shaltout, Cairo

Kamel Saleh, Tanta

Khadiga el Ashmawy,Cairo

Khaled el-khashab,Fayoum

laila mahmoud, Tanta

loay el-Ahwal, Tanta

mahmoud fareed, Beni Suef

mahmoud omar, Monofiya

mamdouh el-Nahas, Mansoura

manal Almasery, Fayoum

megahed Abu el-magd, Mansoura

moghazy mahgoub, Ain Shams

mohamed Assi, Zagazig

mohamed Awad, Zagazig

mohamed eissa, Cairo

mohamed fahmy AbdelAziz , Cairo

mohamed Kamar, Zagazig

mohamed khattab, Cairo

mohamed Salam, Zagazig

mona Abdel-Salam, Ain Shams

mona mansour, Cairo

morsi Arab, Alex

mostafa Hareedy, Assiut

Nabil Kafrawy, Alex

Nesreen Kotb, Tanta

ola Khairalla, MOH

olfat fawzy, Al Azhar

omar el-Saadany, Cairo

osama Abdel-Azeem, Cairo

raafat rashwan, Cairo

ragheb refaai, Mansoura

rokaya Abdel Aziz, Cairo

Salah Argoon, Assiut

Sally Abu el-Sooud, Fayoum

Sayed Abdel-fattah,Mansoura

Sherif Hafez, Cairo

Soaad Soltan, Cairo

wael farrag, Tanta

walaa Anwar, Assiut

yasser Abdel reaouf, Tanta

Zenab Abdel-Baset, Al-Azhar

is the capital and largest city of Egypt. The city’s metropolitan area is the largest in the Middle East and the Arab world, and the 15th-largest in the world, and is associated with ancient Egypt, as the famous Giza pyramid complex and the ancient city of Memphis are located in its geographical area. Located near the Nile Delta, modern Cairo was founded in 969 CE by the Fatimid dynasty, but the land composing the present-day city was the site of

ancient national capitals whose remnants remain visible in parts of Old Cairo. Cairo has long been a center of the region’s political and cultural life, and is titled “the city of a thousand minarets” for its preponderance of Islamic architecture.Cairo has the oldest and largest film and music industries in the Arab world, as well as the world’s second-oldest institution of higher learning, Al-Azhar University. Many international media, businesses, and organizations have regional headquarters in the city; the Arab League has had its headquarters in Cairo for most of its existence.With a population of 6.76 million spread over 453 square kilometers (175 sq mi), Cairo is by far the largest city in Egypt. An additional 9.5 million inhabitants live in close proximity to the city. Cairo, like many other mega-cities, Cairo’s metro, one of two in Africa, ranks among the fifteen busiest in the world, with over 1 billion annual passenger rides. The economy of Cairo was ranked first in the Middle East in 2005, and 43rd globally on Foreign Policy’s 2010 Global Cities Index.

Reference: https://en.wikipedia.org

CAIRO

11 12

orGANiZotioNAl NoteS AUDioViSUAl iNStrUctioNS

registration Hours

> Registration desk will be ready on Thursday 8th March 2018 at 12:00 PM> Registration desk will be ready on Friday 9th March 2018 at 8:00 AM> Registration desk will be ready on Saturday 10th March 2018 at 8:00 AM language

The Official Language is EnglishAll lectures and presentations will be held in English Language .There will be no translation available .

website

www.uedaegypt.org

weather

Thursday 8th March 2018 Hi 33 Low 19 Partly sunny & hotFriday 9th March 2018 Hi 31 Low 16 Partly sunny & very warmSaturday 10th March 2018 Hi 28 Low 14 Partly sunny

important Notes

Please, Wear your conference badges all the time as attendees will not be allowed to be present in the conference premises without their personal badges. Smoking is absolutely forbidden. Mobile phones should be set to silent or powered off during all conference sessions. Children will not be allowed to enter the conference area.

Dear Speaker,You will soon be presenting at the congress and we Want this experience to go as smoothly as possible for you. On behalf of the congress, Extreme will manage the Audiovisual Services and provide you with assistance before, during and after your lecture. Submitting your Presentation:

• All presentations should be entirely in English. Please submit your presentation on Flash. Please make sure that the saved file(s) contain all media files Included in your presentation.

For PC usersAll Presentations should be created by Microsoft Office For presentations Included videos it’s preferred to create it using the latest Microsoft PowerPoint

For Mac usersIt’s preferred to create your presentation using Microsoft Office for Mac. Keynote files will be converted to Microsoft PowerPoint file to be compatible with our devices.

Hall Guidelines• Please arrive at the congress hall 10 minutes prior to the beginning of your session. • Thank you for abiding by the allocated duration of your presentation. • A computerized countdown timer will be displayed on screen and will automatically close the presentation once the time is finished. • Alt congress presentations will be recorded as a webcasts and allocated on the congress website.

13 14

AccommoDAtioN SPoNSeriNG comPANieS

EL-OROUBA, QISM EL-NOZHA, CAIRO GOVERNORATE

11736, CAIRO, EGYPT

(002) 02 22677730

El Orouba St, Sheraton Al Matar, Cairo, Cairo Governorate

(002) 02 22698144

info@tolipelgalaa.com

HILTON CAIRO ( Fairmont ), Heliopolis

TOLIP El Galaa, Heliopolis

15

ScieNtific ProGrAm

Thursday,8 March 2018

12:00 PM Registration 60 min.

( Pituitary gland )(moderator: khaled el-Hadidy - mahmoud fareed, ( rock canyon Hall)

Chairperson:Amr El-Meligy Mohamed Eissa Mona Mansour Assem Zayada Olfat Fawzy Zenab Abdel-Baset

1:00 PM Pituitary tumour and craniopharyngiomasSoaad Soltan, Cairo

20 min.

1:20 PM Prolactinomas.Assem Zayada, Cairo

25 min.

1:45 PM Acromegaly.Khaled El-Hadidy, Beni Suef

20 min.

2:05 PM Discussion 15 min.

2:20 PM Short stature. Hanaa Kandeel, Al-Azhar

20 min.

2:40 PM Diabetes insipidusRokaya Abdel Aziz, Cairo

20 min.

3:00 PM endocrine emergencies Mona Abdel-Salam, Ain Shams

20 min.

3:20 PM Discussion 15 min.

Session 1 ( Diabetes Future )(each talk will have 20 min: 15 min for the presentation and 5 min for discussion)

Chairperson:Hassan Mohy El-Dien Huda Hussien Raafat Rashwan Sally Abu El-Sooud

1:00 PM Prevention of type 1 Dm.Hesham El-Hefnawy, NIDE

20 min.

1:20 PM Glycemic control beyond HbA1cBanshi Saboo, India

20 min.

1:40 PM the D in Diabetes Nabil Naggar, KSA

20 min.

17

ScieNtific ProGrAmSession 2 ( Women and Diabetes )

(each talk will have 20 min: 15 min for the presentation and 5 min for discussion)

Chairperson:Amal Khalifa Gehan AbdelKader Ihab Salem V. Mohan

2:00 PM GDm Puzzle- relevance for Asian womenAkhtar Hussain, Norway

20 min.

2:20 PM Sexual Dysfunction in Diabetic women. Shabeen Naz Masood, Pakistan

20 min.

2:40 PM woman Health and diabetes Lobna El-Toony, Assiut

20 min.

Session 3 ( Hidden Iceberg )(each talk will have 20 min: 15 min for the presentation and 5 min for discussion)

Chairperson:Emad Meshriki Ibtisam Zakaria Mohamed Assi Mohamed Khattab

3:00 PM iGf1/fGfi and DiabetesMegahed Abu El-Magd, Mansoura

20 min.

3:20 PM circadian rhythm and diabetes Mohamed Kamar, Zagazig

20 min.

3:40 PM Personalized (Precision) medicine for Diabetes – the time has come V. Mohan, India

20 min.

4:00 - 4:20 PM Coffee Break

4:20 - 4:50 PM Opening

Session 4 ( WHO/NCD )

4:50 PM Gojka roglic, SwitzerlandWHO Global

5 min.

4:55 PM Slim Slama, lebanon EMRO NCD

5 min.

5:00 PM ibtihal fadhel, UAe NCDA Regional and Global

5 min.

5:05 PM ola Khairalla, moH NCD Unit Eg MOH

5 min.

5:10 PM Adel el Sayed, Sohag Eg NCDA

5 min.

5:15 PM open Discussion 65 min.

19

ScieNtific ProGrAmSession 5 ( (puzzle in Diabetes )

(each talk will have 20 min: 15 min for the presentation and 5 min for discussion)

Chairperson:Abdel Aziz Hemidy Assem Zayada Moghazy Mahgoub Samad Shera Sherif Hafez

6:20 PM Prevention of obesity in meNA region, why and How?Adel El-Sayed, Sohag

20 min.

6:40 PM Progress in our understanding of type 2 diabetes Akhtar Hussain, Norway

20 min.

7:00 PM Prevention of diabetes is possible through community empowerment V. Mohan, India

20 min.

Servier Symposium

Chairperson:Eman Thabet Lobna El-Toony Mesbah Kamel

7:20 PM Gliclazide mr: Update Mohamed khattab

30 min.

Sanofi Symposium

Chairperson:Lobna El-Toony Mesbah Kamel Mohamed Mashahit

7:50 PM the insulin of today Khaled El-Hadidy

30 min.

MSD Symposium

Chairperson:Adel Abdel Aziz Mesbah Kamel Sufian Khalid

8:20 PM clinical consideration while prescribing oHA in practice Omar El-Saadany

15 min.

Dinner

21

ScieNtific ProGrAm

Friday,9 March 2018

( Adrenal gland )(moderator: Dr.lobna el-toony - walaa Anwar ), ( rock canyon Hall)

Chairperson:Fahmy Amara Hanan MahmoudKhadiga El Ashmawy Mohamed Fahmy AbdelAziz

9:00 AM mineralocorticoid excess.Mohamed Awad, Zagazig

20 min.

9:20 AM cushing”s syndromes.Wael Farrag, Tanta

20 min.

9:40 AM Adrenal insufficiency. Ehab Salem, Zagazig

20 min.

10:00 AM Discussion 15 min.

10:15 AM Adrenal incidentalomas Alaa Abdel Salam, Monofiya

20 min.

10:35 AM Pheochromcytoma. Eman El-Shorbagy, Zagazig

20 min.

10:55 PM Discussion 10 min.

Session 6 ( Diabetes and micro vascular complications )(each talk will have 20 min: 15 min for the presentation and 5 min for discussion)

Chairperson:A.K Azad Khan Basma Abdel-Moez Mesbah Kamel Ragheb Refaai

10:00 AM Hepatorenal Syndrome & DiabetesAshraf Talaat, Banha

20 min.

10:20 PM Diabetesfor primary health providersMahmoud Omar, Monofiya

20 min.

10:40 PM economy of diabetes in developing countries Morsi Arab, Alex

20 min.

11:00-02:00 PM Friday Prayer & coffee Break

23

ScieNtific ProGrAmSession 7 ( Renal, retinal and heart in diabetes )

(each talk will have 20 min: 15 min for the presentation and 5 min for discussion)

Chairperson:Banshi Saboo Loay El-Ahwal Mesbah kamel Sirelkhatim Siri

2:00 PM Updates in diabetic nephropathyHemat Elewaa, Cairo

20 min.

2:20 PM recent advances in retinopathy: Novel mechanisms and treatment of diabetic retinopathy. Sehnaz Karadeniz, Turkey

20 min.

2:40 PM cardiovascular outcome among diabetics Ali Abdel-Rahim, Alex

20 min.

3:00 PM Stem cell facts or ficionAbbas Orabi, Zagazig

20 min.

Session 8 ( Diabetic Neuropathy and Peripheral vascular disease )(each talk will have 20 min: 15 min for the presentation and 5 min for discussion)

Chairperson:Hala Elebidi Hanan Gawish Kebira Benabed Nesreen Kotb

3:20 PM therapy of Diabetic neuropathy. we can do better. Mamdouh El-Nahas, Mansoura

20 min.

3:40 PM Peripheral vascular disease Jamal Belkhadir, Morocco

20 min.

4:00 PM Diabetic Autonomic Neuropathy Hardik Chandarana , India

20 min.

Session 9 ( Joint committee Between DASG and UEDA )(each talk will have 20 min: 15 min for the presentation and 5 min for discussion)

Chairperson:Abdullah El-Hamaq Adel El Sayed Akhtar Hussain Shashank Joshi

4:20 PM innovative approach for Prevention of diabetes with Special reference to resource constrain socities. A.K Azad Khan, Bangladesh

20 min.

4:40 PM care of type 1 diabetics in DASG region, an experience of insulin my life (iml) project Asher Fawwad, Pakistan

20 min.

5:00 PM Diabetes and Hypertension Samad Shera, Pakistan

20 min.

100 IU

١

A2 “Double wing“ BB007 Cairo Festival City 3rd floor, 5th settlement, New Cairo, EgyptPhone: +202 26965300 Fax: +202 22685636

For further information, contact Eli Lilly & Company’s Scientific Office:

DIA

-LD

-000

56- E

G-0

1/17

25

ScieNtific ProGrAmNovartis Symposium

Chairperson:khaled El-Hadidy Mesbah kamel

5:20 PM Galvus in the era of precision medicine Bahaa Zayed

20 min.

liptis Symposium

Chairperson:khaled El-khashab Mesbah kamel

5:40 PM Glybofen Keeps Diabetic patient protected Lobna El-Toony

20 min.

Boehringer Symposium

Chairperson:Khaled El-Hadidy Lobna El-Toony

6:00 PM empagliflozin changing the paradigm of type ii Diabetes management Mesbah Kamel

20 min.

Dinner

27

ScieNtific ProGrAm

Saturday,10 March 2018

( Bone metabolic diseases , Puberty , Oncology. )(moderator: mohamed mashahait)(08:00-09:00 Am - Sally Abu el-Sooud), ( rock canyon Hall)

Chairperson:Ahmed Abdel-kawy Hammad Ayman Almonofy Eman Ezzat Hala El Toukhy Manal Almasery Mohamed Salam

9:00 AM Parathyroid disordersEngy Abdel-Wahhab, Tanta

18 min.

9:18 AM osteoporosisGhada El-Sagheer, Minya

18 min..

9:36 AM multiple endocrine neoplasia Mohamed Mashahit, Fayoum

18 min.

9:54AM Delayed pubertyAliaa Al Aghoury, Alex

18 min.

10:12 AM female hyperandrogenism Fawzy El Mosalamy, Zagazig

18 min.

10:30 PM Discussion 10 min.

Workshop (GDM) ( Rock Canyon Hall )

Chairperson:Asmaa kassem Hanan Mahmoud

11:15 AM experience of GDm projects between india Pakistan and egypt Shabeen Naz MasoodLobna El-Toony V. Mohan

60 min.

Session 10 ( Diabetes in special situations )(each talk will have 20 min: 15 min for the presentation and 5 min for discussion)

Chairperson:Ghada El-Sagheer Sayed Abdel-Fattah Megahed Abu Elmagd Samad Shera

10:00 AM Diabetes mena road map for better care Abdulbasit, Pakistan

20 min.

10:20 AM microbiota and diabetes updates Fareed Fawzy, Zagazig

20 min.

10:40 AM Diabetes in the context of low body mass index. the management challenge Bishwajit Bhowmik, Bangladesh

20 min.

29

ScieNtific ProGrAm

Session 11 ( (Diabetes and special populations )(each talk will have 20 min: 15 min for the presentation and 5 min for discussion)

Chairperson:Bishwajit Bhowmik Hala El-Sherif Khaled El-Hadidy Mostafa Hareedy

11:00 AM Diabetes in elderlyZaman Shaikh, Pakistan

20 min.

11:20 AM management, glycemic control and complications in adults with diabetes:two years findings of changing Diabetes Barometer in BangladeshMuhammad Abdus Samad, Bangladesh

20 min.

11:40 AM t2Dm in adolescent Mohamed Mashahit, Fayoum

20 min.

Session 12 ( Diabetes with comorbidities )(each talk will have 20 min: 15 min for the presentation and 5 min for discussion)

Chairperson:Eman El-Shorbagy Fareed fawzy Mohamed Mashahit Mohamed Khattab

12:00 PM New horizons in diabetes dyslipidemia management Diaa Ewais, KSA

20 min.

12:20 PM Psychiatric aspects of diabetes mellitus Hany Hamed, Beni suef

20 min.

12:40 PM Dm with periodontal Disease Yasser Abdel Reaouf, Tanta

20 min.

Session 13 ( Diabetes Future Therapy )(each talk will have 20 min: 15 min for the presentation and 5 min for discussion)

Chairperson:Fahmy Amara Kamal Saleh Lobna El-Toony Khaled El-Hadidy

1:00 PM integrated Diabetes Service Emad Hamed, Qena

20 min.

1:20 PM Diabetes and ramadan Inass Shaltout, Cairo

20 min.

Session 14 ( Meet the experts )(each talk will have 20 min: 15 min for the presentation and 5 min for discussion)

Chairperson:Laila Mahmoud lobna El-Toony Mohamed Mashahit Nabil Kafrawy

1:40 PM Vitamin D important tips Khaled El-Hadidy, Beni suef

20 min.

2:00 PM Diabetes and Hajj Yakoob Ahmedani, Pakistan

20 min.

2:20 PM m health: empowerment of patients. Mesbah Kamel, Minya

20 min.

100 IU

١

A2 “Double wing“ BB007 Cairo Festival City 3rd floor, 5th settlement, New Cairo, EgyptPhone: +202 26965300 Fax: +202 22685636

For further information, contact Eli Lilly & Company’s Scientific Office:

DIA

-LD

-000

56- E

G-0

1/17

31

ScieNtific ProGrAm

Novo Nordisk Symposium

Chairperson:Khaled El-Hadidy Mohamed Mashahit

2:40 PM Ultra long basal insulin, what’s new? Mesbah kamel

20 min.

Astra Symposium

Chairperson:Lobna El-Toony Mesbah kamel

3:00 PM SGlt2, A paradigm Shift in type 2 Diabetes management Osama Abdel-Azeem

20 min.

Closing Ceremony

Lunch

34

NoteS

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

35

NoteS

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................

.........................................................................................................................................................................................................................